Pila Pharma Signals Rising Obesity Drug Interest at Lisbon Biotech Summit
Pila Pharma has drawn fresh attention from global investors and pharmaceutical partners after sharing updates during Bio Europe Spring in Lisbon, where the company highlighted growing momentum around its oral TRPV1 antagonist aimed at the obesity market. With funding secured into 2027, the biotech firm is positioning itself as a potential challenger to dominant weight […]